|
|
|
Volumn 33 Suppl 1, Issue , 2006, Pages 189-192
|
|
Phase II study of S-1, a novel oral fluorouracil, in advanced non-small-cell lung cancer
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC ANTIMETABOLITE;
OXONIC ACID;
S 1 (COMBINATION);
TEGAFUR;
ADULT;
AGED;
ANOREXIA;
ARTICLE;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
DRUG ADMINISTRATION;
DRUG COMBINATION;
FEMALE;
HUMAN;
LUNG NON SMALL CELL CANCER;
LUNG TUMOR;
MALE;
MIDDLE AGED;
NEUTROPENIA;
ORAL DRUG ADMINISTRATION;
PHASE 2 CLINICAL TRIAL;
QUALITY OF LIFE;
REMISSION;
ADMINISTRATION, ORAL;
ADULT;
AGED;
ANOREXIA;
ANTIMETABOLITES, ANTINEOPLASTIC;
CARCINOMA, NON-SMALL-CELL LUNG;
DRUG ADMINISTRATION SCHEDULE;
DRUG COMBINATIONS;
FEMALE;
HUMANS;
LUNG NEOPLASMS;
MALE;
MIDDLE AGED;
NEUTROPENIA;
OXONIC ACID;
QUALITY OF LIFE;
REMISSION INDUCTION;
TEGAFUR;
|
|
EID: 33747382737
PISSN: 03850684
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (3)
|
|
References (0)
|
